Neuigkeiten zu Krebstherapien

In den letzten Jahren wurden große Fortschritte auf dem Gebiet der Krebsbehandlungen erzielt – insbesondere auf dem aufstrebenden Gebiet der Krebsimmuntherapie. Werfen Sie einen Blick auf die nachfolgende Auswahl an wissenschaftlichen Publikationen und gewinnen Sie einen Eindruck darüber, wie wichtig klinische Forschung ist – oder besuchen Sie unsere Facebook-Seite, um weitere Informationen zu erhalten:

20. März 2019

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Read more

14. März 2019

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.

Read more

08. März 2019

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Read more

28. Februar 2019

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Read more

22. Februar 2019

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

Read more

12. Februar 2019

Lorlatinib Shows Overall and Intracranial Activity in ALK-Positive NSCLC

Read more

31. Januar 2019

PACIFIC Trial of Durvalumab Sets Standard in Stage III Unresectable NSCLC

Read more

27. Januar 2019

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Read more

22. Januar 2019

Exercise as part of cancer treatment

Read more

12. Dezember 2018

SABCS 2018: SOLAR-1: Liquid Biopsies in Predicting Benefit of Alpelisib in PIK3CA-Mutant Breast Cancer

Read more

30. November 2018

ELOQUENT-3: Addition of Elotuzumab to Pomalidomide and Dexamethasone in Previously Treated Multiple Myeloma

Read more

24. November 2018

Obesity-induced Immune Dysfunction and its Consequences in Cancer

Read more

15. November 2018

The Mediterranean Diet Reduces the Risk and Mortality of the Prostate Cancer: A Narrative Review

Read more

11. November 2018

Exercise Therapy for Symptom Management and Treatment in Patients With Cancer

Read more

08. November 2018

Durvalumab Improves Overall Survival in Unresectable Stage III NSCLC

Read more

27. Oktober 2018

Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses’ Health Studies

Read more

15. Oktober 2018

Nivolumab and Ipilimumab Effective against Melanoma. That Has Spread to the Brain.

Read more

09. Oktober 2018

The Association Between Dietary Quality and Overall and Cancer-Specific Mortality Among Cancer Survivors, NHANES III

Read more

09. Oktober 2018

A Menu for Cancer Risk Reduction? Five truths about the role of food and diet in cancer prevention

Read more

14. August 2018

Abemaciclib/Pembrolizumab Combo Shows Early Promise for HR+/HER2- Breast Cancer

Read more

19. Juli 2018

What is 'checkpoint therapy' and why did it win the medicine Nobel prize?

Read more

19. Juli 2018

What is 'checkpoint therapy' and why did it win the medicine Nobel prize?

Read more

15. Juli 2018

IMpassion130: Atezolizumab Plus Nab-Paclitaxel in Metastatic or Locally Advanced Triple-Negative Breast Cancer

Read more

11. Juni 2018

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer.

Read more

11. Juni 2018

Immune-System Therapy Eradicated Breast Cancer in New Breakthrough

Read more

11. Mai 2018

Immunotherapy and radiation in glioblastoma.

Read more

01. April 2018

Prognostic significance of marital status in breast cancer survival: A population-based study.

Read more

23. März 2018

Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.

Read more

28. Februar 2018

Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.

Read more

05. Februar 2018

Physician age and outcomes in elderly patients in hospital in the US: observational study

Read more

30. Januar 2018

Proof-of-Principle Study of Combination Checkpoint Inhibitor Plus Trastuzumab in HER2-Positive Advanced Breast Cancer

Read more

26. Januar 2018

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Read more

20. Januar 2018

American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance)

Read more

20. Januar 2018

Preventive Effects of Cocoa and Cocoa Antioxidants in Colon Cancer

Read more

18. Januar 2018

Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer

Read more

15. Januar 2018

FDA Grants DS-8201 Breakthrough Designation for HER2+ Breast Cancer

Read more

28. Oktober 2017

Clinical decision-making for immunotherapy in metastatic renal cell carcinoma

Read more

22. Oktober 2017

Osimertinib Granted Breakthrough Therapy Designation for First-Line Treatment of EGFR Mutation–Positive NSCLC

Read more

19. Oktober 2017

Cancers Associated With Overweight and Obesity Make Up 40% of Cancers Diagnosed in the United States

Read more

25. September 2017

FDA Approves Daratumumab in Combination With Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Read more

19. September 2017

The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme

Read more

06. September 2017

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

Read more

05. September 2017

FDA Approves Panitumumab for Use in Wild-Type RAS Metastatic Colorectal Cancer

Read more

20. Juli 2017

Angiosarcoma treated successfully with anti-PD-1 therapy - a case report

Read more

12. Juni 2017

Genentech: Beyond The Cycle

Read more

10. Juni 2017

Cancer Drug Proves to Be Effective Against Multiple Tumors

Read more

08. Juni 2017

Immunotherapy Combination Shows Promise in Early Stage Triple Negative Breast Cancer

Read more

06. Juni 2017

ASCO 2017: Chance of Colon Cancer Recurrence Nearly Cut in Half in Patients Who Consume Nuts

Read more

03. Juni 2017

Checkpoint Inhibitors Advancing in Multiple GI Cancers

Read more

31. Mai 2017

Duke researchers develop treatment that triples survival time of brain cancer patients

Read more

31. Mai 2017

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients

Read more

13. Mai 2017

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

Read more

13. Mai 2017

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

Read more

17. April 2017

Brain Trust: Cutting-Edge Treatments for Glioblastoma on the Rise

Read more

16. April 2017

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Read more

02. April 2017

Nivolumab in renal cell carcinoma: latest evidence and clinical potential

Read more

12. März 2017

Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer

Read more

08. März 2017

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

Read more

07. März 2017

Ovarian cancer and the immune system — The role of targeted therapies

Read more

21. Februar 2017

Nivolumab in patients with DNA mismatch repair deficient/microsatellite instability high metastatic colorectal cancer: Update from CheckMate 142

Read more

08. Februar 2017

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma: an international, multicentre, open-label, phase 2 trial.

Read more

05. Februar 2017

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

Read more

16. November 2016

Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report

Read more

13. November 2016

Immunotherapy moves to the front lines in fight against lung cancer

Read more

09. November 2016

Impressive Early Data for Rovalpituzumab Tesirine in Small Cell Lung Cancer

Read more

24. Oktober 2016

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

Read more

12. Oktober 2016

The Science Behind Guided Imagery

Read more

16. September 2016

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

Read more

27. August 2016

The development and use of the E75 (HER2 369-377) peptide vaccine

Read more

27. August 2016

Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial

Read more

18. August 2016

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

Read more

01. August 2016

Harnessing the immune system to fight cancer

Read more

13. Juli 2016

Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide

Read more

26. April 2016

Neoadjuvant T-DM1/Pertuzumab Combo Boosts pCR in HER2+ Breast Cancer

Read more

14. April 2016

Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors

Read more

14. April 2016

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial

Read more

10. März 2016

Peptide vaccines in breast cancer: The immunological basis for clinical response

Read more

25. Februar 2016

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial

Read more

23. Januar 2016

With Immunotherapy, Glimmers of Progress against Glioblastoma

Read more

15. Januar 2016

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

Read more

22. November 2015

Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers

Read more

22. November 2015

Adjuvant HER2/neu peptide cancer vaccines in breast cancer

Read more

09. Oktober 2015

Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study

Read more

08. Oktober 2015

Immune modulation for cancer therapy

Read more

02. Oktober 2015

Case report: A breast cancer patient treated with GcMAF, sonodynamic therapy and hormone therapy

Read more

02. Oktober 2015

Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.

Read more

30. September 2015

Cancer immunotherapy with peptide-based vaccines: What have we achieved? Where are we going?

Read more

Neuigkeiten

27. Februar 2019

Die Hallwang Clinic ist eine spezialisierte onkologische Privatklinik, die ...

05. Dezember 2018

Das Team der Hallwang Private Oncology Clinic bietet herausragende Leistungen...

Logo Hallwang Clinic Germany

Kontaktieren Sie uns

Kontaktieren Sie uns für eine kostenlose Beratung durch unser spezialisiertes Onkologieteam

Rechts